Article
Optimized conditions for gene transduction into primary immune cells using viral vectors
31 Jul 2023
Abstract excerpt
Chimeric antigen receptor (CAR) T cell therapy has emerged as a promising modality for anti-cancer treatment. Its efficacy is quite remarkable in hematological tumors. Owing to their excellent clinical results, gene- modified cell therapies, including T cells, natural killer (NK) cells, and macrophages, are being actively studied in both academia and industry. However, the protocol to make CAR immune cells is too...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
